Sucralfate oral

FDA Drug Profile — Sucralfate

Drug Details

Generic Name
Sucralfate oral
Brand Names
Sucralfate
Application Number
ANDA209356
Sponsor
Precision Dose, Inc.
NDC Codes
1
Dosage Forms
SUSPENSION
Routes
ORAL
Active Ingredients
SUCRALFATE

Indications and Usage

INDICATIONS AND USAGE Sucralfate Oral Suspension is Sucralfate oral suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.in the short-term (up to 8 weeks) treatment of active duodenal ulcer.

Warnings

WARNINGS Fatal complications, including pulmonary and cerebral emboli have occurred with inappropriate intravenous administration of sucralfate oral suspension. Administer sucralfate oral suspension only by the oral route. Do not administer intravenously.